AEON Biopharma, Inc. (AEON)
ASE – Real vaqt narxi. Valyuta: USD
1.16
+0.16 (16.00%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
1.10
-0.06 (-5.16%)
Bozordan keyin: Mar 27, 2026, 7:55 PM EDT

ASE – Real vaqt narxi. Valyuta: USD
1.16
+0.16 (16.00%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
1.10
-0.06 (-5.16%)
Bozordan keyin: Mar 27, 2026, 7:55 PM EDT
Daromad taqsimoti ma'lumotlari hali hisoblanmagan.
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 0.90 | 6.05 | 6.0 | |
| Tezkor likvidlik nisbati | 0.90 | 5.63 | 6.0 | |
| Qarz/Kapital nisbati | N/A | 0.30 | 1.0 | |
| Qarz/Aktivlar nisbati | 2.09 | 1.04 | 1.0 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 3.0 | |||
| KO‘RSATKICH | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Jami daromad | N/A | N/A | N/A | N/A | N/A |
| Yalpi foyda | N/A | -68K | -99K | -97K | -81K |
| Operatsion daromad | -2M | -48M | -53M | -28M | -17M |
| Sof foyda | 8M | -53M | -385M | 42M | -3K |
| EBITDA | -2M | -48M | -53M | -28M | -17M |
| NOMI | KOEFF. | SANOAT | 5 YIL | BALL |
|---|---|---|---|---|
| Yalpi marja % | N/A | -11.73 | 1.0 | |
| Operatsion marja % | N/A | -24.60 | 1.0 | |
| Sof marja % | N/A | -172.20 | 1.0 | |
| EBITDA marja % | N/A | -201.27 | 1.0 | |
| Pul oqimi marja % | N/A | -156.39 | 1.0 | |
| O‘rtacha ball | 1.0 | |||
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | -105.47 | 1.0 |
| Keyingi chorak | N/A | N/A | 1.0 |
| Joriy yil | N/A | -100.84 | 1.0 |
| Keyingi yil | N/A | -8162.3 | 1.0 |
| O‘rtacha ball | 1.0 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 999 | 31.68 | 35 | -24.14 | 7.8 |
| Yil/Yil | 999 | 26.46 | 96.61 | 12.15 | 9.3 |
| 3 yil o‘rtacha | 999 | -420.58 | N/A | -758.88 | 3.3 |
| 5 yil o‘rtacha | N/A | N/A | N/A | N/A | 1.0 |
| O‘rtacha ball | 5.4 | ||||
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Umumiy qarz $18.3M naqd pul zahiralaridan ($5.9M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy majburiyatlar $8.2M jami joriy aktivlardan $7.4M oshib ketdi, likvidlik muammolarini ko'rsatadi
Qarz/kapital nisbati (-0.9) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$2.6M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi